Shield Therapeutics plc
SHIEF News Today: Stay Updated with the Latest Shield Therapeutics plc News in Real Time
Find SHIEF news now at Meyka AI. Stay informed with the latest Shield Therapeutics plc stocks updates, including price news, market analysis, and expert insights.
Jefferies Maintains Hold on Perrigo Company plc (PRGO) Feb 26, 2026 $18 PT
Jefferies keeps Hold on Perrigo Company plc with $18 PT; PRGO analyst rating maintained Feb 26, 2026
Vol 15,112 hits ORPH.IR Open Orphan (EURONEXT) 27 Feb 2026: watch EUR 0.14 support
Pre-market volume spike in ORPH.IR stock to 15,112, trading at EUR 0.14 on EURONEXT; quick analysis and price outlook
Jefferies Maintains Buy, PT $45 for Viridian Therapeutics (VRDN) Feb 2026
VRDN analyst rating: Jefferies maintains Buy with $45 PT and Evercore keeps Outperform in Feb 2026
Citigroup upgrades AngloGold Ashanti Plc (AU) to Buy Feb 26, 2026
Citigroup upgrade raises AU analyst rating for AngloGold Ashanti Plc on Feb 26, 2026
KYMR: Kymera Therapeutics Maintained Outperform by RBC Capital Feb 26 2026
RBC Capital maintained KYMR analyst rating at Outperform and raised PT to $108 on Feb 26 2026; implications and Meyka AI grade B+
Barclays Maintains Overweight on C4 Therapeutics (CCCC) Feb 26, 2026
Barclays and Cowen maintain ratings on C4 Therapeutics. Read Feb 26, 2026 CCCC analyst rating and implications
H.C. Wainwright Maintains Buy on United Therapeutics (UTHR) Feb 2026
H.C. Wainwright maintained Buy on United Therapeutics (UTHR) and raised the PT to $600 in Feb 2026 — UTHR analyst rating update
Smurfit Kappa SK3.IR EURONEXT closed EUR 41.44 26 Feb 2026: heavy volume view
SK3.IR stock: Smurfit Kappa closed EUR 41.44 on 26 Feb 2026 with heavy volume and a Meyka AI forecast of +37.86%
FTI.PA TechnipFMC Euronext after-hours €5.91 Feb 2026: most-active, upside seen
After-hours volume spikes on FTI.PA stock at €5.912; analysis covers valuation, news, Meyka AI forecast and trading setup